glp-1 drugs for parkinson's disease How a 'blockbuster' treatment diabetes and obesity might slow or stop – Van Andel Institute GLP-1 Medications: Everything You Need

Results from preclinical studies indicate that endogenous and exogenous GLP-1 reduces dopamine in synapses and promotes the potentiation of GABAergic neurotransmitter release via MHb-IPN circuits, attenuating the reinforcing properties of nicotine [22]

Brown JC, Mutt V, Pederson RA

These forward-looking statements can be identified by the use of forward-looking terminology, including the words believe, estimate, anticipate, expect, assume, imply, intend, plan, may, will, potential, project, predict, continue, could, confident, confidence, or should, or, in each case, their plural, their negative or other variations or comparable terminology

You have tried some of these

See: Are beneficiaries eligible for the Medicare GLP-1 Bridge if they are prescribed a GLP-1 for a condition other than weight management? at Reply Is there a place we can send complaints regarding what could be considered discrimination, unfairness, or inequality

Source: Polaris Market Research Analysis Regional Analysis Which Region Leads the Global GLP-1 Market